Novel Drug‐Testing Platform for Vascular Injury‐induced Intimal Hyperplasia Using a Microphysiological System
Advanced Healthcare Materials · 2025-12 · 14 (31)
DOI: 10.1002/adhm.202500602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 11.08.2025. Verfasst von Ungsig Nam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Scientific Instrumentation, Korea Basic Science Institute (KBSI), Daejeon, 34133, Republic of Korea. Hauptthemen laut MEDLINE: Hyperplasia, Vascular System Injuries, Tunica Intima. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Basic Science Institute.
Abstract (Originalsprache)
Drug‐coated balloons (DCBs) and drug‐eluting stents (DESs) with antiproliferative drugs have been developed to prevent restenosis. However, some patients who undergo DCB or DES procedures still experience restenosis. Therefore, it is essential to explore therapeutic agents for DCBs and DESs. Furthermore, alternative platforms addressing current experimental model limitations are necessary for disease research. Here, a 3D model of vascular injury‐induced intimal hyperplasia is developed by using a microphysiological system (MPS). This model effectively replicated the endothelial denudation, proliferation, and migration of vascular smooth muscle cells (VSMCs), and vascular inflammation associated with the disease. Using this disease model, it is shown that antiproliferative drugs suppress VSMC proliferation but worsen endothelial denudation. In addition, potential alternatives are investigated to antiproliferative drugs and tested various drugs aimed at reducing inflammation. Partial improvements are found in VSMCs treated with DPI and in the endothelium treated with quercetin. When diphenyleneiodonium (DPI) and quercetin are combined, VSMC proliferation, migration, and vascular inflammation are reduced without impairing re‐endothelialization. This disease model shows promise; this study may offer new treatment insights for DCBs and DESs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Scientific Instrumentation, Korea Basic Science Institute (KBSI), Daejeon, 34133, Republic of Korea.
- Department of Bio-Analytical Science, University of Science and Technology, Daejeon, 34113, Republic of Korea.
- Department of Mechanical Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
ORCID-Profile: Ungsig Nam, HyeMi Kim, Jeong Ah Kim, Ki-Hwan Nam, Kye-Sung Lee, Hwan Hur, Jessie S Jeon, Ji Yong Bae
Förderung
- National Research Foundation of Korea
- Korea Basic Science Institute
Zitieren
APA
Nam, U., Kim, H., Kim, J. A., Nam, K. H., Lee, K. S., Hur, H., Jeon, J. S., & Bae, J. Y. (2025). Novel Drug‐Testing Platform for Vascular Injury‐induced Intimal Hyperplasia Using a Microphysiological System. Advanced Healthcare Materials, 14(31). https://doi.org/10.1002/adhm.202500602
Vancouver
Nam U, Kim H, Kim JA, Nam KH, Lee KS, Hur H, et al. Novel Drug‐Testing Platform for Vascular Injury‐induced Intimal Hyperplasia Using a Microphysiological System. Advanced Healthcare Materials. 2025;14(31). doi:10.1002/adhm.202500602
BibTeX
@article{Nam2025,
author = {Nam, Ungsig and Kim, HyeMi and Kim, Jeong Ah and Nam, Ki-Hwan and Lee, Kye-Sung and Hur, Hwan and Jeon, Jessie S and Bae, Ji Yong},
title = {Novel Drug‐Testing Platform for Vascular Injury‐induced Intimal Hyperplasia Using a Microphysiological System},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {31},
doi = {10.1002/adhm.202500602}
}
EUVIMED